KalVista Pharmaceuticals, Inc(NASDAQ:KALV) 
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HA...
Website: http://www.kalvista.com
Founded: 2004
Full Time Employees: 56
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 11.00
H 11.28
L 9.94
C 10.71
V 1,341,800
10EMA 10.71
20EMA 10.71
60EMA 10.71
120EMA 10.71
250EMA 10.71